WebDisclosure WebDisclosure
Basculer en Français
10964 Companies
239972 Keywords
168740 Articles
129111 Press releases
Headlines Articles Press releases Altius Bioventures Remove
  1. Home
  2. Companies
  3. Altius Bioventures
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/10/2024 at 14:05, 2 years ago

    Altius Bioventures Launches The CGT Industry Atlas, Mapping the Innovation Landscape

    Innovation Healthcare Cell And Gene Therapy Technology Landscape Industry Guide
  • BRIEF

    published on 09/10/2024 at 14:05, 2 years ago

    Altius Bioventures lance l'Atlas de l'industrie CGT, qui cartographie le paysage de l'innovation

    Innovation Soins De Santé Thérapie Cellulaire Et Génique Paysage Technologique Guide De L'industrie
  • PRESS RELEASE

    published on 09/10/2024 at 14:00, 2 years ago

    Altius Bioventures Launches The CGT Industry Atlas, Mapping out the Cell and Gene Therapy Technology Innovation Landscape

    Altius Bioventures announces release of CGT Industry Atlas, providing comprehensive guide to cell and gene therapy technologies landscape, categorizing sector into core elements
    Innovation Gene Therapy Cell Therapy Altius Bioventures CGT Industry Atlas
    Logo of Altius Bioventures
  • PRESS RELEASE

    published on 11/15/2023 at 15:00, 2 years 9 months ago

    Altius Bioventures Initiates Fundraising for Altius Bioventures Fund I

    Logo of Altius Bioventures
Accesswire
  • Published on 09/11/2026 at 04:00, 3 hours 44 minutes ago

    Torq Announces Debt Settlement and Corporate Update

  • Published on 09/10/2026 at 22:25, 9 hours 19 minutes ago

    Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer

  • Published on 09/10/2026 at 17:46, 13 hours 58 minutes ago

    Groete Access Road Nears Completion

  • Published on 09/10/2026 at 15:20, 16 hours 24 minutes ago

    MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026

  • Published on 09/10/2026 at 15:00, 16 hours 44 minutes ago

    All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE
EQS Group
  • Published on 09/11/2026 at 07:30, 13 minutes ago

    NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs

  • Published on 09/11/2026 at 00:05, 7 hours 38 minutes ago

    Club Offers for Travel Enthusiasts in Germany

  • Published on 09/11/2026 at 00:01, 7 hours 43 minutes ago

    Club Offers for Travel Enthusiasts in Germany

  • Published on 09/10/2026 at 22:39, 9 hours 4 minutes ago

    EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law

  • Published on 09/10/2026 at 22:10, 9 hours 33 minutes ago

    flatexDEGIRO with changes to the Supervisory Board

View all EQS
Les Echos
  • Published on 09/11/2026 at 07:00, 44 minutes ago

    Transparantiekennisgeving van Baltisse Groep

  • Published on 09/11/2026 at 07:00, 44 minutes ago

    Transparency notification by Baltisse Group

  • Published on 09/11/2026 at 07:00, 44 minutes ago

    BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY

  • Published on 09/11/2026 at 07:00, 44 minutes ago

    BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ

  • Published on 09/10/2026 at 19:30, 12 hours 14 minutes ago

    Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy